Filter
702
Filtered Results: 702
Text search:
FDA
Featured
Recommendations
93
New Publications
138
Language
Document type
No document type
337
Guidelines
191
Studies & Reports
88
Manuals
27
Fact sheets
25
Strategic & Response Plan
15
Training Material
9
Resource Platforms
3
Infographics
3
Brochures
2
Situation Updates
2
Countries / Regions
India
40
Latin America and the Carribbean
21
Ghana
19
Russia
17
Philippines
15
Germany
12
Brazil
12
Myanmar / Burma
12
Global
11
Congo, Democratic Republic of
11
South Africa
10
Middle East and North Africa
9
Kenya
8
USA
8
West and Central Africa
8
Syria
7
Nigeria
7
Argentina
7
Ecuador
7
Colombia
6
Ukraine
6
Senegal
6
Western and Central Europe
6
Uganda
6
Yemen
6
Angola
6
Nepal
5
Sierra Leone
5
Mozambique
5
Paraguay
5
Eastern Europe
5
Ethiopia
5
South Sudan
5
Indonesia
5
Thailand
4
Burkina Faso
4
Peru
4
Eastern Europe and Central Asia
4
France
4
East and Southern Africa
4
Sudan
4
Mali
4
Liberia
4
Benin
3
Rwanda
3
Chile
3
Guinea
3
Africa
3
Venezuela
3
Tanzania
3
South–East Asia Region
3
Spain
3
Bolivia
3
Bangladesh
3
Tajikistan
2
El Salvador
2
Albania
2
Niger
2
Haiti
2
Asia
2
Guinea-Bissau
2
Jordan
2
Saudi Arabia
2
Portugal
2
Côte d’Ivoire / Ivory Coast
2
Vietnam
2
Namibia
2
Iraq
2
Mexico
1
Turkey
1
Kazakhstan
1
Cameroon
1
Singapore
1
Congo-Brazzaville
1
Malawi
1
Zimbabwe
1
Morocco
1
Qatar
1
Mauritania
1
Armenia
1
Cambodia
1
Dominican Republic
1
Tunisia
1
United Kingdom
1
Belarus
1
Israel
1
Lebanon
1
Nicaragua
1
Moldova
1
Egypt
1
Honduras
1
Chad
1
Libya
1
Botswana
1
Somalia
1
Madagascar
1
Cuba
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
227
Clinical Guidelines
85
Pharmacy & Technologies
23
Women & Child Health
20
Public Health
14
Key Resources
9
Capacity Building
5
Toolboxes
COVID-19
159
Mental Health
69
TB
63
HIV
53
Pharmacy
39
AMR
36
Ebola
31
Rapid Response
20
Specific Hazards
13
NTDs
11
Planetary Health
10
NCDs
10
Zika
9
Refugee
7
Cholera
5
Natural Hazards
4
Caregiver
4
Conflict
3
Global Health Education
3
Disability
1
Health Financing Toolbox
1
The conduct of COVID-19 vaccine trials in the context of a candidate vaccine being issued with Emergency Use Designation raises challenging ethical questions, including in relation to the use of placebo controls and unblinding of trial participants in current and future COVID-19 vaccine trials. This...
MOH clinical practice guidelines
These WHO interim recommendations on the use of the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
fir...
nterim guidance, first issued 25 January 2021, updated 15 June 2021, updated 19 November 2021, updated 23 February 2022, updated 18 August 2022
Overcoming barriers in low- and middle-income countries
For the first time, this year’s report includes information on hepatitis C diagnostics. With a focus on selected countries with diverse HCV epidemics, the report provides updates on the various dimensions of access to HCV diagnostics and pha...
Änderung gegenüber der Version vom 26.1.2021: Aktualisierung der Informationen über monoklonale Antikörper und Rekonvaleszentenplasma
An Action Framework and annexe to Immunization Agenda 2030 (Draft version)
27 January 2021
This catalogue provides tools and information resources to support EU/EEA countries in addressing the challenging issue of vaccine hesitancy. The catalogue provides examples of practices that can serve as a resource for other countries. The project was developed in the context of ECDC’s support fo...
Временное руководство23 декабря 2020 г.
A practitioner’s guide to the principles of COVID-19 vaccine communications.
The factors that lead people to make choices to take vaccines are nuanced and affected by how they see the world, their perceptions of the choices people like them will make, who they trust, their perceptions of risk,...
This technical guidance aims to provide guidelines to laboratories and relevant stakeholders in the European Union (EU), European Economic Area (EEA) and other countries in the WHO European region in making decisions on establishing sequencing capacities and capabilities, in making decisions on whic...
28 Jan. 2021. L’objet de ce document est de fournir des orientations provisoires sur la sécurité biologique en laboratoire applicable à l’analyse d’échantillons cliniques issus de patients.
Diese Faktenboxen sollen Ihnen helfen, Nutzen und Schaden einer Schutzimpfung gegen COVID-19 abzuwägen. Die Informationen und Zahlen stellen keine endgültige Bewertung dar. Sie basieren auf den derzeit besten wissenschaftlichen Erkenntnissen.
23 February 2021
This document describes the medical devices required for the clinical management of COVID-19, selected and prioritized according to the latest available evidence and interim guidelines. This includes: oxygen therapy, pulse oximeters, patient monitors, thermometers, infusion and suc...
El documento "Lista de productos sanitarios prioritarios para la respuesta a COVID-19 y especificaciones técnicas asociadas" complementa esta directriz.
Este documento proporciona una orientación provisional sobre la calidad, las características de rendimiento y las normas conexas de los equi...
Ce document fournit des orientations provisoires sur la qualité, les caractéristiques de performance et les normes connexes des équipements de protection individuelle (EPI) à utiliser dans le contexte de COVID-19. Il s'agit notamment des dispositifs médicaux prioritaires de l'OMS, à savoir : l...
National Essential Diagnostic List
recommended
